Bioerodible polymers for drug delivery in bone
US5286763A · kind A · utility
92Cited by
11References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 30, 1992 |
| Grant date | Feb 15, 1994 |
| Priority date | — |
| Expiry date | Jun 30, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2430/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Bioerodible polymers which degrade completely into nontoxic residues over a clinically useful period of time, including polyanhydrides, polyorthoesters, polyglycolic acid, polylactic acid, and copolymers thereof, are used for the delivery of bioactive agents, including antibiotics, chemotherapeutic agents, inhibitors of angiogenesis, and simulators of bone growth, directly into bone.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.